Your browser doesn't support javascript.
loading
Therapeutic Effect of PE+CRRT Combined with Chemotherapy on Children with Severe EBV-HLH and Non-EBV-HLH / 中国实验血液学杂志
Journal of Experimental Hematology ; (6): 259-264, 2021.
Article Dans Chinois | WPRIM | ID: wpr-880064
ABSTRACT
OBJECTIVE@#To investigate the difference in the therapeutic effect of plasma exchange and continuous renal replacement therapy (PE+CRRT) combined with chemotherapy in the treatment of children with severe Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) and non-EBV-HLH.@*METHODS@#The clinical data of 21 cases of all children with severe HLH treated by PE+CRRT combined with chemotherapy from January 2017 to January 2020 were collected and retrospectively analyzed. According to the presence of EBV infection, the children were divided into EBV@*RESULTS@#Among the 21 children, 14 were divided into the EBV@*CONCLUSION@#PE+CRRT combined with chemotherapy can reduce serum ferritin quickly, then improve organ function, and increase the overall survival rate of severe HLH, and it is a good effect on children with severe EBV-HLH and non-EBV-HLH.
Sujets)
Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Échange plasmatique / Études rétrospectives / Herpèsvirus humain de type 4 / Infections à virus Epstein-Barr / Lymphohistiocytose hémophagocytaire / Thérapie de remplacement rénal continue Type d'étude: Étude observationnelle Limites du sujet: Enfant / Humains langue: Chinois Texte intégral: Journal of Experimental Hematology Année: 2021 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Échange plasmatique / Études rétrospectives / Herpèsvirus humain de type 4 / Infections à virus Epstein-Barr / Lymphohistiocytose hémophagocytaire / Thérapie de remplacement rénal continue Type d'étude: Étude observationnelle Limites du sujet: Enfant / Humains langue: Chinois Texte intégral: Journal of Experimental Hematology Année: 2021 Type: Article